Modeling

Center for Disease Analysis. Colorado Prevalence and Incidence of Hepatitis C Virus Infection: A Modeling Study. Sept. 2017.

Buti M, Calleja JL, García-Samaniego J, Serra MÁ, Crespo J, Romero M, Simón MÁ, Turnes J, Blasco AJ, Lázaro P, Robbins S, Razavi H; en representación del Grupo para el Estudio y Modelización Epidemiológica de la Hepatitis C en España (GEMEHCE). Elimination of hepatitis C in Spain: Adaptation of a mathematical model based on the […]

Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176. doi: 10.1016/S2468-1253(16)30181-9. Epub 2016 Dec 16. PMID: 28404132. Summary Collaborators Polaris Observatory HCV Collaborators: Sarah Blach, Stefan Zeuzem, Michael Manns, Ibrahim Altraif, Ann-Sofi Duberg, David H Muljono, Imam Waked, Seyed M Alavian, Mei-Hsuan Lee, Francesco Negro, Faisal Abaalkhail, Ahmed Abdou, Maheeba Abdulla, Antoine Abou Rached, Inka […]

Duberg AS, Blach S, Falconer K, Kåberg M, Razavi H, Aleman S. The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies. Scand J Gastroenterol. 2015 Feb;50(2):233-44. doi: 10.3109/00365521.2014.990505. Epub 2014 Dec 17. PMID: 25515032. Summary Objective Recently, new highly effective direct-acting antivirals (DAAs) against hepatitis C […]

Cramp ME, Rosenberg WM, Ryder SD, Blach S, Parkes J. Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality. BMC Gastroenterol. 2014 Aug 7;14:137. doi: 10.1186/1471-230X-14-137. PMID: 25100159; PMCID: PMC4128826. Summary Background The societal, clinical and economic burden imposed by the complications […]